Akebia Announces Presentation of Results from its Phase 2b Study of AKB6548 in NonDialysis Patients with Anemia Related to Chronic Kidney Disease at the International Society of Nephrologys World Congress of Nephrology
Bioportfolio,
Data Achieved Clinically Important Safety and Efficacy Goals Company to Host Conference Call and Webcast Slide Presentation at…